Status:
COMPLETED
2-stage Cervical Cancer Screening in Botswana
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Cervical Cancer
HIV/AIDS
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
Cervical cancer is the leading cause of cancer death among women in Botswana. The burden of cervical cancer is largely related to the high prevalence of HIV in Botswana (22%), as HIV is known to be a ...
Detailed Description
Cervical cancer screening programs vary across settings and there is no clear guidance for effective screening programs for HIV-positive women. Evaluating the performance of algorithms that include hu...
Eligibility Criteria
Inclusion
- ≥25 years of age
- HIV-positive
- Competent to understand study procedures and give informed consent.
Exclusion
- Currently pregnant
- Currently menstruating or having persistent vaginal discharge
- Previous hysterectomy
- Previous diagnosis of cervical cancer
Key Trial Info
Start Date :
April 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT03324009
Start Date
April 20 2018
End Date
January 31 2020
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Marina Hospital
Gaborone, Botswana